Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100042771Phase 4Completed
Phase 4, randomised, double-blind trial of jiuwei zhenxin in generalized anxiety disorder (GAD) (2 arms), sponsored by Beijing Anding Hospital. Primary endpoint: HAMA total score. Started Oct 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100042771.